Suchergebnisse - Dexamethasone OR corticosteroid

21

Inhaled corticosteroids for cystic fibrosis : a review of clinical effectiveness

Erschienen: Ottawa, CADTH, March 12, 2019

CADTH rapid response report: summary with critical appraisal

Version 1.0.

von Peprah, K. | McCormack, S.

22

Intra-articular hyaluronic acid for viscosupplementation in osteoarthritis of the hand, shoulder, and temporomandibular joint : a review of clinical effectiveness and safety

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, July 25, 2019

CADTH rapid response report: summary with critical appraisal

Version 1.0.

von Tran, K. | Loshak, H.

23

Pharmacoeconomic review report : indication : for the maintenance treatment of steroid-responsive bronchial asthma as prophylactic therapy in patients 12 years of age and olderFluticasone propionate (Aermony Respiclick) (Teva Canada Innovation)

Erschienen: Ottawa (ON), CADTH, January 2019

CADTH common drug review

Final (with redactions).

24

Intranasal corticosteroids for the management of chronic rhinosinusitis or nasal polyposis in cystic fibrosis : a review of clinical effectiveness

Erschienen: Ottawa, CADTH, March 18, 2019

CADTH rapid response report: summary with critical appraisal

Version 1.0.

von Tran, K. | McCormack, S.

25

Pharmacoeconomic review report : indication : for topical treatment of mild-to-moderate atopic dermatitis in patients two years of age and olderCrisaborole ointment, 2% (Eucrisa) (Pfizer Canada Inc.)

Erschienen: Ottawa (ON), CADTH, April 2019

CADTH common drug review

Final with redactions.

26

Clinical review report : indication : for topical treatment of mild to moderate atopic dermatitis in patients 2 years of age and olderCrisaborole ointment, 2% (Eucrisa) (Pfizer Canada Inc.)

Erschienen: Ottawa (ON), CADTH, April 2019

CADTH common drug review

27

A treatise on topical corticosteroids in dermatology : use, misuse and abuse

Erschienen: Singapore, Springer, [2018]

SpringerLink, Bücher

von Lahiri, K.

28

Handbook of brain tumor chemotherapy, molecular therapeutics, and immunotherapy

Erschienen: London, Academic Press, an imprint of Elsevier, [2018]

Second edition

von Newton, H.

29

Pharmacoeconomic review report : indication : an add-on maintenance treatment of adult patients with severe eosinophilic asthmaBenralizumab (Fasenra) (AstraZeneca Canada Inc.)

Erschienen: Ottawa (ON), CADTH, August 2018

CADTH common drug review

Final with redactions.

30

CADTH Canadian drug expert committee recommendation : indication : severe eosinophilic asthmaBenralizumab (Fasenra -- Astrazeneca Canada Inc.)

Erschienen: Ottawa (ON), CADTH, August 2018

CADTH common drug review

Final.

Filter & Sortierung